<img alt="" height="1" width="1" />
Cubist Pharmaceuticals Inc. (CBST) Has Jumped To A New High On Study Results
RTT News
Cubist Pharmaceuticals Inc. (CBST: Quote) announced positive results from its Phase 3 clinical trial of its antibiotic candidate ceftolozane/tazobactam in complicated urinary tract infections Monday morning. Ceftolozane/tazobactam met its primary endpoint of ...
Cubist says urinary tract infection drug succeeds in studyReuters India
Cubist Announces Positive Top-Line Results from Phase 3 Trial of ...Financial Post

all 7 news articles &raquo;


More...